{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T18:42:31Z","timestamp":1779043351208,"version":"3.51.4"},"reference-count":60,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n               Background This study aimed to assess the association between the risk of\n                    colorectal cancer (CRC) and exposure to mood stabilizers, antidepressants, and\n                    antipsychotics in patients with affective disorders.<\/jats:p><jats:p>\n               Methods This nested case-control study used data from the National Health\n                    Insurance Database of Taiwan collected between 2001 and 2011. All participants\n                    in this study had affective disorders. Then, 1209 patients with CRC and 1:10\n                    matched controls were identified based on their demographic and clinical\n                    characteristics. A logistic regression model adjusted for demographic and\n                    clinical characteristics was used to determine the risk of developing CRC after\n                    exposure to psychotropic drugs.<\/jats:p><jats:p>\n               Results Among patients with affective disorders, exposure to mood\n                    stabilizers (reported as odds ratio; 95% confidence interval; 0.75; 0.57\u20130.98),\n                    antidepressants (0.83; 0.70\u20130.97), second-generation antipsychotics (0.67;\n                    0.52\u20130.86), and first-generation antipsychotics (0.65; 0.52\u20130.81) were\n                    associated with a reduced risk of CRC compared to patients who were not exposed.\n                    When considering specific drugs, carbamazepine (0.34; 0.12\u20130.95), valproic acid\n                    (0.66; 0.46\u20130.95), gabapentin (0.44; 0.20\u20130.99), fluoxetine (0.82; 0.68\u20130.99),\n                    paroxetine (0.63; 0.45\u20130.87), and venlafaxine (0.72; 0.55\u20130.95) were associated\n                    with a lower risk of CRC.<\/jats:p><jats:p>\n               Conclusion Exposure to psychotropic drugs in patients with affective\n                    disorders is associated with a lower risk of CRC compared to those who were not\n                    exposed. Although the causal relationship between psychotropic drug exposure and\n                    reduced risk of CRC could not be inferred directly, these findings may help\n                    clinicians and patients in clinical decision-making.<\/jats:p>","DOI":"10.1055\/a-2479-9430","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T19:15:56Z","timestamp":1734462956000},"page":"216-225","source":"Crossref","is-referenced-by-count":1,"title":["Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients\n                    with Affective Disorder: A Nested Case-Control Study"],"prefix":"10.1055","volume":"58","author":[{"given":"Tien-Wei","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, E-Da Dachang Hospital, I-Shou University,\n                    Kaohsiung, Taiwan"},{"name":"Department of Psychiatry, E-Da Hospital, I-Shou University, Kaohsiung,\n                    Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Jen","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital, Taipei,\n                    Taiwan"},{"name":"Department of Psychiatry, School of Medicine, College of Medicine,\n                    National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzeng-Ji","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Taipei Veterans General Hospital,\n                    Hsinchu Branch, Hsinchu, Taiwan"},{"name":"Institute of Hospital and Health Care Administration, National\n                    Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6516-1073","authenticated-orcid":false,"given":"Mu-Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Taipei Veterans General Hospital, Taipei,\n                    Taiwan"},{"name":"Department of Psychiatry, School of Medicine, College of Medicine,\n                    National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1138-5586","authenticated-orcid":false,"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Beitou Branch, Tri-Service General Hospital,\n                    National Defense Medical Center, Taipei, Taiwan"},{"name":"Department of Psychiatry, National Defense Medical Center, Taipei,\n                    Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13092025","article-title":"A review of colorectal cancer in terms of epidemiology, risk factors,\n                    development, symptoms and diagnosis","volume":"13","author":"T Sawicki","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"956923","DOI":"10.3389\/fonc.2022.956923","article-title":"Understanding the basis of major depressive disorder in oncological patients:\n                    Biological links, clinical management, challenges, and lifestyle medicine","volume":"12","author":"O Fraile-Martinez","year":"2022","journal-title":"Front Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neubiorev.2021.03.034","article-title":"Risk of cancer in bipolar disorder and the potential role of lithium:\n                    International collaborative systematic review and meta-analyses","volume":"126","author":"G Anmella","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.puhe.2017.04.026","article-title":"Depression and cancer risk: A systematic review and meta-analysis","volume":"149","author":"Y Jia","year":"2017","journal-title":"Public Health"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ijc.25322","article-title":"Colorectal cancer risk in relation to antidepressant medication use","volume":"128","author":"J Chubak","year":"2011","journal-title":"Int J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pds.1808","article-title":"Antidepressant use and colorectal cancer risk","volume":"18","author":"P F Coogan","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1470-2045(06)70622-2","article-title":"Use of antidepressants and risk of colorectal cancer: A nested case-control\n                    study","volume":"7","author":"W Xu","year":"2006","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/ijms.13834","article-title":"Inverse association between sodium channel-blocking antiepileptic drug use and\n                    cancer: Data mining of spontaneous reporting and claims databases","volume":"13","author":"M Takada","year":"2016","journal-title":"Int J Med Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061560","article-title":"New use for old drugs: The protective effect of risperidone on colorectal\n                    cancer","volume":"12","author":"V C Chen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","article-title":"Cancer risk among users of neuroleptic medication: A population-based cohort\n                    study","volume":"95","author":"S O Dalton","year":"2006","journal-title":"Br J Cancer"},{"key":"ref11","first-page":"277","article-title":"Evaluation of the potential anti-cancer activity of the antidepressant\n                    sertraline in human colon cancer cell lines and in colorectal cancer-xenografted\n                    mice","volume":"33","author":"I Gil-Ad","year":"2008","journal-title":"Int J Oncol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e37230","DOI":"10.5812\/ircmj.37230","article-title":"Comparison of anticancer effects of carbamazepine and valproic acid","volume":"18","author":"L Akbarzadeh","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/ijc.24537","article-title":"Incidence of cancer and antidepressant medication: Record linkage study","volume":"126","author":"J Haukka","year":"2010","journal-title":"Int J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/1516-4446-2012-1693","article-title":"Bipolar disorder prevalence: A systematic review and meta-analysis of the\n                    literature","volume":"37","author":"A S Clemente","year":"2015","journal-title":"Braz J Psychiatry"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the\n                    United States","volume":"75","author":"D S Hasin","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2147\/NDT.S146098","article-title":"Functional impairment in patients with major depressive disorder: The 2-year\n                    PERFORM study","volume":"14","author":"L Hammer-Helmich","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/NMD.0000000000000425","article-title":"The burden of repeated mood episodes in bipolar I disorder: Results from the\n                    National Epidemiological Survey on Alcohol and Related Conditions","volume":"204","author":"A T Peters","year":"2016","journal-title":"J Nerv Ment Dis"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1176\/appi.ps.201200143","article-title":"Cigarette smoking among persons with schizophrenia or bipolar disorder in\n                    routine clinical settings, 1999-2011","volume":"64","author":"F Dickerson","year":"2013","journal-title":"Psychiatr Serv"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jad.2021.12.110","article-title":"Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general\n                    obesity, and abdominal obesity in patients with bipolar disorder: A systematic\n                    review and meta-analysis","volume":"300","author":"Y K Liu","year":"2022","journal-title":"J Affect Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: A systematic review and meta-analysis of\n                    longitudinal studies","volume":"67","author":"F S Luppino","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/add.13604","article-title":"Cigarette smoking and depression comorbidity: Systematic review and proposed\n                    theoretical model","volume":"112","author":"A R Mathew","year":"2017","journal-title":"Addiction"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/add.15735","article-title":"Associations of common mental disorder with alcohol use in the adult general\n                    population: A systematic review and meta-analysis","volume":"117","author":"J A Puddephatt","year":"2022","journal-title":"Addiction"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e205371","DOI":"10.1001\/jamapediatrics.2020.5371","article-title":"Risk of substance use disorder and its associations with comorbidities and\n                    psychotropic agents in patients with autism","volume":"175","author":"J S Huang","year":"2021","journal-title":"JAMA Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/schbul\/sbz126","article-title":"The risk of sexually transmitted infections following first-episode\n                    schizophrenia among adolescents and young adults: A cohort study of 220 545\n                    subjects","volume":"46","author":"C S Liang","year":"2020","journal-title":"Schizophr Bull"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1200\/JCO.22.01189","article-title":"Risk of major psychiatric disorders among children and adolescents surviving\n                    malignancies: A nationwide longitudinal study","volume":"41","author":"T W Hsu","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1017\/S003329171800332X","article-title":"Risk and coaggregation of major psychiatric disorders among first-degree\n                    relatives of patients with bipolar disorder: A nationwide population-based\n                    study","volume":"49","author":"M H Chen","year":"2019","journal-title":"Psychol Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2337\/dc15-1807","article-title":"Risk of developing type 2 diabetes in adolescents and young adults with autism\n                    spectrum disorder: A nationwide longitudinal study","volume":"39","author":"M H Chen","year":"2016","journal-title":"Diabetes care"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1038\/mp.2017.217","article-title":"Co-aggregation of major psychiatric disorders in individuals with first-degree\n                    relatives with schizophrenia: A nationwide population-based study","volume":"23","author":"C M Cheng","year":"2018","journal-title":"Molecular psychiatry"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291719003696","article-title":"Familial coaggregation of major psychiatric disorders among first-degree\n                    relatives of patients with obsessive-compulsive disorder: A nationwide\n                    study","author":"M H Huang","year":"2020","journal-title":"Psychol Med"},{"key":"ref30","first-page":"1","article-title":"Incorporating development stratification of Taiwan townships into sampling\n                    design of large scale health interview survey","volume":"4","author":"C Y Liu","year":"2006","journal-title":"J Health Management (Chin)"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies:\n                    Development and validation","volume":"40","author":"M E Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/pcn.13326","article-title":"Risk of retinal disease in patients with bipolar disorder: A nationwide cohort\n                    study","volume":"76","author":"T W Hsu","year":"2022","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/head.14306","article-title":"Attention deficit hyperactivity disorder and risk of migraine: A nationwide\n                    longitudinal study","volume":"62","author":"T W Hsu","year":"2022","journal-title":"Headache"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19148739","article-title":"Dose-dependent proton pump inhibitor exposure and risk of type 2 diabetes: A\n                    nationwide nested case-control study","volume":"19","author":"H Y Kuo","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"352","DOI":"10.4161\/chan.21910","article-title":"Voltage-gated sodium channels and metastatic disease","volume":"6","author":"W J Brackenbury","year":"2012","journal-title":"Channels (Austin)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00280-014-2384-1","article-title":"Phase I study of anti-VEGF monoclonal antibody bevacizumab and histone\n                    deacetylase inhibitor valproic acid in patients with advanced cancers","volume":"73","author":"J J Wheler","year":"2014","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10549-012-2102-9","article-title":"Therapeutic potential for phenytoin: Targeting Na(v)1.5 sodium channels to\n                    reduce migration and invasion in metastatic breast cancer","volume":"134","author":"M Yang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"ref38","first-page":"166","article-title":"Histone deacetylase inhibitors: Molecular mechanisms of action and clinical\n                    trials as anti-cancer drugs","volume":"3","author":"H J Kim","year":"2011","journal-title":"Am J Transl Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1386207325666220421104008","article-title":"In-silico optimization of frizzled-8 receptor inhibition activity of\n                    carbamazepine: Design new anti-cancer agent","volume":"26","author":"R Ahmadi","year":"2023","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1016\/j.lfs.2005.01.003","article-title":"Carbamazepine is an inhibitor of histone deacetylases","volume":"76","author":"A S Beutler","year":"2005","journal-title":"Life Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00280-015-2695-x","article-title":"Phase I trial of valproic acid and lenalidomide in patients with advanced\n                    cancer","volume":"75","author":"M A Bilen","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2867-6-2","article-title":"Antineoplastic effects of the DNA methylation inhibitor hydralazine and the\n                    histone deacetylase inhibitor valproic acid in cancer cell lines","volume":"6","author":"A Chavez-Blanco","year":"2006","journal-title":"Cancer Cell Int"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0300-483x(94)02966-x","article-title":"Pancreatic acinar cell neoplasia in male Wistar rats following 2 years of\n                    gabapentin exposure","volume":"98","author":"R E Sigler","year":"1995","journal-title":"Toxicology"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13104-019-4103-9","article-title":"High dose gabapentin does not alter tumor growth in mice but reduces arginase\n                    activity and increases superoxide dismutase, IL-6 and MCP-1 levels in Ehrlich\n                    ascites","volume":"12","author":"L P da Cunha","year":"2019","journal-title":"BMC Res Notes"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brainres.2012.11.032","article-title":"Gabapentin reduces allodynia and hyperalgesia in painful diabetic neuropathy\n                    rats by decreasing expression level of Nav1.7 and p-ERK1\/2 in DRG neurons","volume":"1493","author":"J L Zhang","year":"2013","journal-title":"Brain Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/bcpt.12484","article-title":"Gabapentin, an analgesic used against cancer-associated neuropathic pain:\n                    Effects on prostate cancer progression in an in vivo rat model","volume":"118","author":"I Bugan","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1192\/bjp.bp.116.181362","article-title":"Use of lithium and cancer risk in patients with bipolar disorder:\n                    Population-based cohort study","volume":"209","author":"R Y Huang","year":"2016","journal-title":"Br J Psychiatry"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s12011-012-9510-x","article-title":"Biphasic dose-dependent effect of lithium chloride on survival of human\n                    hormone-dependent breast cancer cells (MCF-7)","volume":"150","author":"M Suganthi","year":"2012","journal-title":"Biol Trace Elem Res"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.euroneuro.2015.04.010","article-title":"Anti-depressant therapy and cancer risk: A nested case-control study","volume":"25","author":"B Boursi","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1248\/bpb.b15-00128","article-title":"Comparison of the anti-tumor effects of selective serotonin reuptake inhibitors\n                    as well as serotonin and norepinephrine reuptake inhibitors in human\n                    hepatocellular carcinoma cells","volume":"38","author":"J Kuwahara","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1111\/jcmm.14011","article-title":"Anticancer activity of paroxetine in human colon cancer cells: Involvement of\n                    MET and ERBB3","volume":"23","author":"W J Jang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e50043","DOI":"10.1371\/journal.pone.0050043","article-title":"Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic\n                    carcinogen mouse model","volume":"7","author":"V Kannen","year":"2012","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.toxlet.2011.04.024","article-title":"Fluoxetine induces preventive and complex effects against colon cancer\n                    development in epithelial and stromal areas in rats","volume":"204","author":"V Kannen","year":"2011","journal-title":"Toxicol Lett"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/00001813-200506000-00015","article-title":"Clinical activity of venlafaxine and topiramate against oxaliplatin-induced\n                    disabling permanent neuropathy","volume":"16","author":"J P Durand","year":"2005","journal-title":"Anticancer Drugs"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"100449","DOI":"10.1016\/j.bbih.2022.100449","article-title":"A systematic review of pharmacologic treatment efficacy for depression in older\n                    patients with cancer","volume":"21","author":"E E Rabin","year":"2022","journal-title":"Brain Behav Immun Health"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic drugs: Pro-cancer or anti-cancer? A systematic review","volume":"79","author":"G Fond","year":"2012","journal-title":"Med Hypotheses"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e0235676","DOI":"10.1371\/journal.pone.0235676","article-title":"Antipsychotics drug aripiprazole as a lead against breast cancer cell line\n                    (MCF-7) in vitro","volume":"15","author":"A Badran","year":"2020","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8120595","article-title":"Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells","volume":"8","author":"F Papadopoulos","year":"2020","journal-title":"Biomedicines"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.canlet.2017.01.042","article-title":"A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug\n                    risperidone as a potential adenocarcinoma treatment","volume":"393","author":"S J Dilly","year":"2017","journal-title":"Cancer Lett"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13318-018-00538-4","article-title":"Clinical pharmacokinetics of a lipid-based formulation of risperidone, VAL401:\n                    Analysis of a single dose in an open-label trial of late-stage cancer\n                    patients","volume":"44","author":"S J Dilly","year":"2019","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2479-9430.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T22:54:41Z","timestamp":1756853681000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2479-9430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":60,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2025,9]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2479-9430","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}